GENEVA, March 24 -- DENALI THERAPEUTICS INC. (161 Oyster Point Blvd.South San Francisco, California 94080) filed a patent application (PCT/US2025/045895) for "ANTI-AMYLOID BETA ANTIBODIES AND METHODS OF USE" on Sep 11, 2025. With publication no. WO/2026/060081, the details related to the patent application was published on Mar 19, 2026.
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Inventor(s): KIM, Do Jin (c/o Denali Therapeutics Inc.161 Oyster Point Blvd.South San Francisco, California 94080), DENNIS, Mark S. (c/o Denali Therapeutics Inc.161 Oyster Point Blvd.South San Francisco, California 94080)
Abstrac...